Ikarian Capital’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Ikarian Capital’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-301	Closed	-$1.56K	–	190
2023 Q3	$1.56K	Sell	301 -1	-0.3%	-$6	﹤0.01%	140
2023 Q2	$2.26K	Sell	302 -24,541	-99%	-$216K	﹤0.01%	122
2023 Q1	$252K	Buy	24,843 +24,541	+8,126%	+$189K	0.06%	104
2022 Q4	$1.19K	Hold	302	–	–	﹤0.01%	85
2022 Q3	$2K	Buy	+302	New	+$2.99K	﹤0.01%	103

Other funds holding PHXM

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Ikarian Capital's PHXM Position: Q4 2023 in Review

Ikarian Capital sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2023, closing a stake of 301 shares — an estimated $1.56K sold.

Ikarian Capital first reported a position in PHXM in Q3 2022 and held it in 5 quarters. The position peaked at $252K in Q1 2023. 1 fund tracked by Wall St. Rank holds PHXM as of Q4 2023.

Ikarian Capital reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Ikarian Capital sold 301 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2023, an estimated $1.56K.
Ikarian Capital first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q3 2022 and held it in 5 quarters.
Ikarian Capital's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $252K in Q1 2023.
1 fund tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2023.

Based on Ikarian Capital's 13F filing for Q4 2023, filed 14 Feb 2024.